TRAVIS BESSELL: Open Payments
NPI 1447571302 · NEW CASTLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,962 in 104 payments from 25 companies in 2025. Trend: 2023 $1,751 · 2024 $1,818 · 2025 $1,962
Food & beverage: $1,962
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $288 |
| Novo Nordisk Inc | 16 | $255 |
| PFIZER INC. | 14 | $204 |
| Lilly USA, LLC | 9 | $185 |
| Amgen Inc. | 10 | $154 |
| GlaxoSmithKline, LLC. | 8 | $151 |
| Exact Sciences Corporation | 3 | $89 |
| Lundbeck LLC | 3 | $81 |
| AstraZeneca Pharmaceuticals LP | 4 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
Products named: QULIPTA, ELIQUIS, MOUNJARO, TRELEGY ELLIPTA, Ozempic, REXULTI, Cologuard Collection Kit, UBRELVY.
Industry payments across PA — which companies pay providers there.
